MCI‐LB patients were more likely to be in receipt of calcium channel blockers and have previously been shown to be more likely to be in receipt of cholinesterase inhibitors14; the administration of cholinesterase inhibitors in MCI‐LB is consistent with local recommendations for managing other clinical features of LB disease,28 even in the absence of dementia. Here, BCHE is linked to dementia.